| Literature DB >> 35388362 |
Fuqiang Wang1,2, Hanlu Zhang1, Guanghao Qiu1,2, Zihao Wang1, Zhiyang Li2, Yun Wang1.
Abstract
Background: Though robotic Ivor Lewis esophagectomy has been increasingly applied, intrathoracic esophagogastrostomy is still a technical barrier. In this retrospective study, we introduced a double-docking technique for intrathoracic esophagogastrostomy to optimize surgical exposure and facilitate intrathoracic anastomosis. Moreover, we compared the clinical outcomes between the double-docking technique and anastomosis with a single-docking procedure in robotic Ivor Lewis esophagectomy.Entities:
Keywords: Ivor Lewis esophagectomy; anastomosis; esophageal carcinoma; esophagus surgery; robotic surgery
Year: 2022 PMID: 35388362 PMCID: PMC8978993 DOI: 10.3389/fsurg.2022.811835
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Location of thoracic port. “Port site a” located in the fifth intercostal space (ICS) at the midaxillary line, “port site b” located in the seventh ICS at the posterior axillary line, “port site c” located in the ninth ICS at the posterior axillary line, “port site d” located in the tenth ICS below the scapular tip, and “port site e” located 10 cm away from port site d in the tenth ICS.
Figure 2Esophageal mobilization and lymph node dissection during the first docking stage. (a) The location of thoracic ports applied in the first docking stage. A 12 mm trocar was placed at “port site B” as a camera port. Two 8 mm trocars were placed at “port site A” and “port site D” for robotic arms 1 and 2, respectively. Another 12 mm trocar was placed at “port site C” as an assistant port. (b) The azygos vein was ligated and then transected. (c) Dissecting the right recurrent laryngeal nerve (RLN) lymph nodes. (d) Dissecting the subcarinal lymph nodes.
Figure 3Esophagogastric anastomosis during the second docking stage. (a) The location of thoracic trocars and mini-thoracotomy applied in the second docking stage. The camera port was relocated in “port site D”. The trocars for robotic arms 1 and 2 were relocated at “port site C” and “port site E”, respectively. “Port site A” was extended to a 4 cm mini-thoracotomy in the fifth ICS. (b) A purse-string suture was placed to secure the esophagus around the anvil. A longitudinal incision in the esophagus was made 1 cm below the purse-string suture to insert the anvil. (c) We transected the esophagus with robotic scissors. (d) The gastric conduit and residual stomach were pulled up into the thoracic cavity. (e) The spike of the circular stapler was connected with the anvil with the help of Cadiere forceps. (f) The surgeon can check the posterior wall of anastomosis under direct vision.
Demographic information of participants.
|
|
|
| ||
|---|---|---|---|---|
| Age, y, median age (range) | 63 (47–77) | 59 (41–71) | 0.17 | |
| Gender | 0.204 | |||
| Male | 38 (84.4%) | 22 (95.7%) | ||
| Female | 7 (15.6%) | 1 (4.3%) | ||
| BMI, kg/m2,median BMI (range) | 22.8 (16.3–30.0) | 23.7 (16.5–29.9) | 0.151 | |
| ASA | 0.446 | |||
| Class 2 | 23 (51.1%) | 14 (60.9%) | ||
| Class 3 | 22 (48.9%) | 9 (39.1%) | ||
| Tumor location | 0.321 | |||
| Middle | 2 (4.4%) | 2 (8.7%) | ||
| Lower | 36 (80.0%) | 19 (82.6%) | ||
| GEJ | 7 (15.6%) | 2 (8.7%) | ||
| pT stage | 0.38 | |||
| Tis | 1 (2.2%) | 0 | ||
| T1a | 2 (4.4%) | 0 | ||
| T1b | 1 (2.2%) | 3 (13.0%) | ||
| T2 | 8 (17.8%) | 6 (26.1%) | ||
| T3 | 32 (71.1%) | 14 (60.9%) | ||
| T4a | 1 (2.2%) | 0 | ||
| pN stage | 0.591 | |||
| N0 | 19 (42.2%) | 10 (43.5%) | ||
| N1 | 16 (35.6%) | 6 (26.1%) | ||
| N2 | 7 (15.6%) | 4 (17.4%) | ||
| N3 | 3 (6.7%) | 3 (13.0%) | ||
| TNM stage | 0.958 | |||
| 0 | 1 (2.2%) | 0 | ||
| IB | 3 (6.7%) | 4 (17.4%) | ||
| II | 1 (2.2%) | 0 | ||
| IIA | 14 (31.1%) | 6 (26.1%) | ||
| IIB | 1 (2.2%) | 0 | ||
| IIIA | 8 (17.8%) | 3 (13.0%) | ||
| IIIB | 13 (28.9%) | 7 (30.4%) | ||
| IVA | 4 (8.9%) | 3 (13.0%) | ||
| Pathology type | 0.133 | |||
| SCC | 36 (80.0%) | 18 (78.3%) | ||
| AC | 6 (13.3%) | 1 (4.3%) | ||
| ASC | 1 (2.2%) | 0 | ||
| NEC | 0 | 1 (4.3%) | ||
| MANEC | 1 (2.2%) | 1 (4.3%) | ||
| Mixed NEC and SCC | 0 | 2 (8.7%) | ||
| Mixed SCC and small cell carcinoma | 1 (2.2%) | 0 | ||
| Comorbidity | ||||
| Diabetes mellitus | 4 (8.9%) | 2 (8.7%) | 0.979 | |
| Hypertension | 9 (20.0%) | 2 (8.7%) | 0.244 | |
| Coronary heart disease | 1 (2.2%) | 2 (8.7%) | 0.253 | |
| Cerebral infarction | 1 (2.2%) | 1 (4.3%) | 0.63 |
BMI, Body mass index; ASA, American Society of Anesthesiologists; GEJ, Gastro-esophageal junction; SCC, Squamous cell carcinoma; AC, Adenocarcinoma; ASC, Adenosquamous carcinoma; NEC, Neuroendocrine carcinoma; MANEC, Mixed adenoneuroendocrine carcinoma.
Perioperative information of participants.
|
|
|
| ||
|---|---|---|---|---|
| Surgical time, median min (range) | 395 (290–480) | 380 (310–522) | 0.368 | |
| Bleeding volume, median ml (range) | 100 (40–300) | 90 (50–150) | 0.183 | |
| Length of ICU stay, median day (range) | 1 (0–23) | 1 (0–3) | 0.16 | |
| Length of hospital stay, median day (range) | 12 (8–34) | 11 (9–31) | 0.25 | |
| LN harvest, median number (range) | 19 (5–41) | 17 (10–32) | 0.944 | |
| Drainage time, median day (range) | 8 (5–71) | 9 (7–29) | 0.414 | |
| Postoperative complications | ||||
| Anastomotic leakage | 5 (11.1%) | 2 (8.7%) | 0.757 | |
| Pneumonia | 5 (11.1%) | 1 (4.3%) | 0.369 | |
| Wound infection | 3 (6.7%) | 0 (0%) | 0.999 | |
| TEF | 1 (2.2%) | 0 (0%) | 1.000 | |
| R0 resection | 44 (97.8%) | 23 (100%) | 1.000 | |
| In-hospital mortality | 1 (2.2%) | 0 (0%) | 1.000 |
TEF, Tracheoesophageal fistula.